Breaking News
0

Celgene Corporation (CELG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Celgene's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
74.69 -3.68    -4.70%
21/05 - Closed. Currency in USD ( Disclaimer )
Pre Market
75.30
+0.61
+0.82%
7:53:48 - Real-time Data
Type: Equity
Market: United States
ISIN: US1510201049 
CUSIP: 151020104
  • Volume: 19,908,509
  • Bid/Ask: 75.20 / 75.95
  • Day's Range: 74.13 - 78.85
Celgene 74.69 -3.68 -4.70%

CELG Overview

 
Information about the Celgene Corporation Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close78.37
Day's Range74.13 - 78.85
Revenue19.5B
Open78.71
52 wk Range74.13 - 147.17
EPS5.2
Volume19,908,509
Market Cap56.8B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)7,662,052
P/E Ratio14.37
Beta1.4
1-Year Change - 36.12%
Shares Outstanding724,827,113
Next Earnings DateJul 25, 2018
What is your sentiment on Celgene?
or
Market is currently closed. Voting is open during market hours.

Celgene Corporation News


Celgene Corporation Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Sell Strong Sell Strong Sell Strong Sell
Technical Indicators BUY Strong Sell Strong Sell Strong Sell Strong Sell
Summary Neutral Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bullish 1H Current
Harami Cross 1H Current
Completed Patterns
Three Outside Down 1W 2 May 06, 2018
Engulfing Bearish 1W 3 Apr 29, 2018
Bullish doji Star 1H 5 May 21, 2018 10:00AM

Celgene Corporation Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 74.69 75.20 75.95 19,908,509 -4.70% USD 21/05  
  Mexico 1,480.00 1,470.00 1,560.00 3,828 -5.39% MXN 21/05  
  Switzerland 76.00 74.50 76.50 116 -6.75% USD 06:24:00  
  Switzerland 80.00 0.00 0.00 0 0.00% CHF 18/05  
  Xetra 64.00 63.82 64.02 6,733 -4.62% EUR 07:37:00  
  Berlin 64.80 63.79 64.05 700 -1.07% EUR 05:33:00  
  Frankfurt 63.70 64.00 64.37 2,155 -4.81% EUR 07:11:00  
  Stuttgart 64.01 63.79 64.05 914 -5.27% EUR 07:36:00  
  TradeGate 63.82 63.71 64.03 5,701 -0.25% EUR 07:26:00  
  Munich 65.27 64.00 64.34 45 -3.45% EUR 06:15:00  
  Vienna 68.770 0.000 0.000 0 0.00% EUR 17/05  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Micron 55.48 56.47 54.53 +2.09 +3.91% 70.86M 21/05  
  Apple 187.63 189.27 186.91 +1.32 +0.71% 18.40M 21/05  
  Tesla 284.49 291.49 281.30 +7.67 +2.77% 9.18M 21/05  
  NVIDIA 244.24 250.03 240.49 -1.70 -0.69% 16.02M 21/05  
  Amazon.com 1,585.46 1,592.05 1,575.00 +11.09 +0.70% 2.93M 21/05  
  Alibaba 197.64 199.79 196.40 +2.64 +1.35% 13.83M 21/05  
  SBI 253.90 259.70 241.00 +9.45 +3.87% 68.71M 06:29:28  
  Facebook 184.49 185.30 183.13 +1.81 +0.99% 13.53M 21/05  
  Netflix 331.82 331.88 325.45 +7.64 +2.36% 6.66M 21/05  
  Microsoft 97.60 98.01 96.80 +1.24 +1.29% 19.42M 21/05  

Celgene Corporation Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

7467

Equity Type

ORD

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CELG Comments

Write your thoughts about Celgene Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Perry
JP3000 1 hour ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bad press right now. Celgene is undervalued at this point. But with the negative press out there, lower prices are possible. Doubt anything matwrial can happen, but I'm looking to buy some of this as news drama pushes them lower.
Reply
0 0
Patrick Valda
PaTT_Philippe 18 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to wait until it drops below $70, because it will. Rebalancing has begun, thanks to higher interest rates.
Reply
0 0
Elon Kim
Elon May 15, 2018 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It looks bad I made a mistake a while ago. It might take a long time to change the direction.
Reply
0 0
AAA Bin
AAA Bin May 15, 2018 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep calm Elon the stock is still good just wait for the Pop
Reply
0 0
Elon Kim
Elon May 15, 2018 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AAA Bin  I actually think it is a time to  buy more....however, I wouldn't hold it for a very long time.
Reply
0 0
Elon Kim
Elon May 15, 2018 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Didn't buy any shares...it looks awful. no sign of recovery at all
Reply
0 0
Pongrácz Csaba
Pongrácz Csaba May 07, 2018 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy it now,very cheap!
Reply
0 1
John Perry
JP3000 Apr 26, 2018 10:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't see a reason for a breakout yet. I'd like to see how it handles the next earnings announcement. Would be much more tempting in the low/mid 80s.
Reply
0 0
Husam AlAhmadi
Husam AlAhmadi Mar 17, 2018 9:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is ready for going long. Buy now and Hold
Reply
1 0
Elon Kim
Elon Mar 14, 2018 4:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Although the market went down today, CELG hold pretty well. All charts look not so bad, and it should do well in coming weeks. March-14
Reply
0 0
Mirco Ardito
Mirco Ardito Feb 28, 2018 4:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now?
Reply
0 0
Randle Mcmurphy
Randle Mcmurphy Feb 16, 2018 1:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This ***is going no where
Reply
0 0
Randle Mcmurphy
Randle Mcmurphy Feb 09, 2018 11:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why the drp?
Reply
0 0
Joe Joe
Joe Joe Dec 22, 2017 12:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Should be a good buy in the low 100's even after the latest failed trial.
Reply
0 0
Evan Tranquilli
Evan Tranquilli Dec 11, 2017 7:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I believe that CELG is at a Perfect time to buy as many shares as you could, upcoming news about a type of cancer, you have solid support at 100, but 100 is also a mental level its as easy as, buy now if it goes below 99 then cut the loss but i dont believe it will do that.
Reply
0 0
Joe Joe
Joe Joe Dec 11, 2017 7:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bad news about the latest trial.
Reply
0 0
future onfutures
future onfutures Oct 30, 2017 10:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
104 at least
Reply
0 0
Theodoridis Thomas
Theodoridis Thomas Oct 30, 2017 10:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what about closing the first of the 2 gaps? :D
Reply
0 0
Oct 30, 2017 10:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
104 or else violation of lines
Reply
0 0
Oct 30, 2017 10:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now the target is even more above. 105.35
Reply
0 0
George Kh
George Kh Aug 27, 2017 8:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi i am planning to invest in the Celgene. Is it good time to buy or need to wait it until reach the minimum?
Reply
0 0
Show previous replies (2)
George Kh
George Kh Aug 27, 2017 8:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Luke Martinokay thanks
Reply
0 0
Leo Tyan
Leo Tyan Aug 27, 2017 8:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Luke Martin Is it a good time now?
Reply
4 0
Pongrácz Csaba
Pongrácz Csaba Aug 27, 2017 8:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2-3 months and have 150
Reply
1 1
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email